scispace - formally typeset
P

Paris Tekkis

Researcher at The Royal Marsden NHS Foundation Trust

Publications -  65
Citations -  3118

Paris Tekkis is an academic researcher from The Royal Marsden NHS Foundation Trust. The author has contributed to research in topics: Colorectal cancer & Total mesorectal excision. The author has an hindex of 28, co-authored 65 publications receiving 2474 citations. Previous affiliations of Paris Tekkis include Imperial College London.

Papers
More filters
Journal ArticleDOI

Preoperative Magnetic Resonance Imaging Assessment of Circumferential Resection Margin Predicts Disease-Free Survival and Local Recurrence: 5-Year Follow-Up Results of the MERCURY Study

TL;DR: High-resolution MRI preoperative assessment of CRM status is superior to AJCC TNM-based criteria for assessing risk of LR, DFS, and OS; therefore, colorectal cancer teams could intensify treatment and follow-up accordingly to improve survival outcomes.
Journal ArticleDOI

Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes.

Aneel Bhangu, +78 more
TL;DR: The aim of the Beyond TME Group was to achieve consensus on the definitions and principles of management, and to identify areas of research priority.
Journal ArticleDOI

One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer.

TL;DR: The aim of this study was to assess which cut‐off (1, 2 or 5 mm) was the best predictor of local recurrence based on preoperative MRI assessment of the circumferential resection margin (CRM).
Journal ArticleDOI

Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer

TL;DR: It is demonstrated that regression of mrEMVI following neoadjuvant chemoradiotherapy (CRT) results in improved outcomes and mr EMVI can be used as an imaging biomarker in rectal cancer.
Journal ArticleDOI

Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.

TL;DR: Resection margin status is more important than primary or recurrent cancer in predicting long-term outcome in patients with locally advanced primary (LAP) cancer and recurrent rectal cancer and local recurrence-free survival.